Articles On Telix Pharmaceuticals (ASX:TLX)

Ending the year on a high note, the S&P/ASX 200 Index (ASX: XJO) rallied on the last trading day of 2022. The benchmark index climbed 0.26% to 7,038.7 points, following in the footsteps of the US stock market last night. Nearly all se...

If investors weren’t already sick of 2022, today’s performance of the S&P/ASX 200 Index (ASX: XJO) was yet another nudge to the downside. By the end of the day, the benchmark index was 0.94% lower at 7,020.1 points. While the rest of...

Highights The ASX 200 benchmark index closed in the red today (December 29), losing 69.00 points or 0.97% to end at 7,017.40 points. The index has lost 1.89% over the last five days, and 6.56% over the last 52 weeks. Energy was the wo...

The share market closed at a seven-week low following solid falls on Wall Street amid fears of another challenging year ahead as rising interest rates crimp corporate profits. The S&P/ASX 200 dropped 66 points or 0.94 per cent to its...

Thursday was another good day on the S&P/ASX 200 Index (ASX: XJO). It closed 0.53% higher at 7,152.5 points. In the lead today was the S&P/ASX 200 Utilities Index (ASX: XUJ). The sector soared 1.6% as all three of its constituents...

Complete data from global Phase III ZIRCON study of Telix’s investigational imaging agent TLX250-CDx in clear cell renal cell carcinoma (ccRCC) will be presented at American Society of Clinical Oncology (ASCO) Genitourinary (GU) Cancer...

The long and short of 2022 is that it was a frustrating period for the Australian biotech sector but one with its fair share of rewards as the sector’s exponents furthered worthy drugs, diagnostics, devices and doodahs. For the sixth year,...

The S&P/ASX 200 Index (ASX: XJO) traded in the green on Tuesday, recovering some of yesterday’s slump. At the end of today’s session, the index was 0.31% higher at 7,203.3 points Tech shares were among the market’s best performe...

MELBOURNE, Australia, Dec. 5, 2022 /PRNewswire/ — Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today announces several key executive leadership appointments and promotions, reflecting the increased commercial focus of the...

Owen Rask and Drew Meredith are back on The Australian Investors Podcast for 2 Sense. This week, Drew and Owen talk crypto, getting financial advice, SMSFs, IVV’s stock split and JP Morgan Asset Management’s 10 year macro outlook. And of co...

According to Oxford Languages, ‘motley’ means “incongruously varied in appearance or character”. But in relation to our Foolish writers, it means they vary greatly with regard to age, risk tolerance, and stage of life as well as in...

The S&P/ASX 200 Index (ASX: XJO) recovered yesterday’s slump and then some today. It closed Tuesday’s session 0.59% higher at 7,181.3 points. That’s despite major commodities, including oil, iron ore, and gold all having fallen o...

MELBOURNE, Australia, Nov. 22, 2022 /PRNewswire/ – Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today announces that a first patient has been dosed in a Phase II investigator-initiated study of TLX101 in combination with...

The S&P/ASX 200 Index (ASX: XJO) slipped on Tuesday as lithium stocks weighed on the market. The index closed 0.07% lower at 7,141.6 points. It followed a weak session on Wall Street overnight in which the Dow Jones Industrial Average...

Nov 14 (Reuters) - Telix Pharmaceuticals: * TELIX ACQUIRES OPTIMAL TRACERS * ENTERED AGREEMENT WITH CALIFORNIA BASED PET IMAGING CENTER TO ACQUIRE OPTIMAL TRACERS Source text for Eikon: Further company coverage:

Telix Pharmaceuticals (TLX) enters an agreement with Northern California PET Imaging Center to acquire radiochemistry specialist Optimal TracersThe company believes the acquisition will “bolster” its in-house radiochemistry development capa...

Nov 14 (Reuters) - Telix Pharmaceuticals: * TELIX ACQUIRES OPTIMAL TRACERS * ENTERED AGREEMENT WITH CALIFORNIA BASED PET IMAGING CENTER TO ACQUIRE OPTIMAL TRACERS Source text for Eikon: Further company coverage:

Nov 14 (Reuters) - Telix Pharmaceuticals: * TELIX ACQUIRES OPTIMAL TRACERS * ENTERED AGREEMENT WITH CALIFORNIA BASED PET IMAGING CENTER TO ACQUIRE OPTIMAL TRACERS Source text for Eikon: Further company coverage:

The Telix Pharmaceuticals Ltd (ASX: TLX) share price is having a volatile day. The biopharmaceutical company’s shares were pushing higher in early trade but have now dropped into the red. At the time of writing, the Telix share price is...

MELBOURNE, Australia and INDIANAPOLIS, Ind., Nov. 14, 2022 /PRNewswire/ — Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today announces that it has entered into an agreement with Sacramento-based Northern California PET Im...

It might be hard to believe after a crazy volatile 2022, but the S&P/ASX 200 Index (ASX: XJO) is still well up since the start of the COVID-19 pandemic.  However, according to Wilsons equity strategist Rob Crookston, there is one usual...

MELBOURNE, Australia, Nov. 11, 2022 /PRNewswire/ – Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company), a commercial-stage biopharmaceutical company focused on the development and commercialisation of diagnostic and therapeutic...

ShareCafeMaterials leads market higher: ASX up 0.6% at close by Peter Milios   Materials is the strongest sector by far in today’s trading. This was due to the initial possibility that China would begin to ease COVID restrictions. As such,...

Highlights:  Australia’s highly comprehensive healthcare system consists of two broad categories, the public and the private healthcare system.  The public healthcare system is called Medicare, and it offers free healthcare services to...

ShareCafeStrict Chinese measures dampen market sentiment: ASX up 0.29% at lunch by Lauren Hayes   US markets finished higher on Friday after a volatile session following the release of the October jobs report, which showed better-than-expec...

Summary of Study Outcomes ZIRCON Phase III study of Telix’s investigational imaging agent TLX250-CDx in clear cell renal cell carcinoma (ccRCC) has met all of its primary and secondary endpoints The study delivered co-primary endpoints...

AusBiotech and Johnson & Johnson Innovation Industry Excellence Awards Industry Leadership Award: Professors Steve Wilton AO and Sue Fletcher AO Company of the Year: Telix Pharmaceuticals Emerging Company of the Year: Fusetec AusBi...

MELBOURNE, Australia, Oct. 27, 2022 /PRNewswire/ — Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) is today pleased to announce that it has been awarded Australian Company of the Year in the 2022 AusBiotech and Johnson &...

MELBOURNE, Australia, Oct. 27, 2022 /PRNewswire/ — Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today announces a collaboration with UniQuest Pty Ltd (UniQuest), the commercialisation company of The University of Queensla...

Australian shares were set to surge after hints of a slowdown in US interest rate rises fuelled a strong end to Wall Street’s best week since June. Wall Street’s main indices jumped more than 2.3 per cent on Friday, priming the S&P/A...

The ASX closed lower on Friday, extending its loss to over 1% for the week Coal and energy stocks gained, while insurance stocks fell Novonix in hot water with the ASX   Local shares fell close to 1% on Friday, ending what has been a vola...

The S&P/ASX 200 Index (ASX: XJO) ended the week in the red once more. The index fell 0.8% to 6,676.8 points on Friday. That leaves it 1.21% lower than it finished last week’s trade. It followed a rough Thursday for New York-listed st...

Highlights The ASX 200 benchmark index closed down today (21 October), losing 53.90 points or 0.80% to end at 6,676.80 points. Over the last five days, the index has lost 1.21% and 9.96% over the last 52 weeks. Utilities and materials...

The share market wrapped up a losing week with a second-straight decline as borrowing costs on both sides of the Pacific tested multi-year highs. The S&P/ASX 200 dropped 54 points or 0.8 per cent this afternoon to 6677. For the we...

ShareCafeGrim start to last trading day for the week: ASX down 0.8% by Peter Milios   Energy and Information Technology are the only sectors up at noon, as the ASX looks to close out a pretty moderate week. The energy sector got a boost fro...

A losing week on the ASX headed towards a downbeat conclusion as declines in banks and industrial companies outweighed slender gains in resource stocks. The S&P/ASX 200 fell 39 points or 0.6 per cent towards a second straight loss af...

27 new biotech companies listed on the ASX the last two years Australian companies need access to US capital to grow The AusBiotech investment conference kicks off next week in WA   The Covid-19 pandemic put Australia’s biotechnology sect...

Australian shares tracked Wall Street lower after the cost of borrowing rose and the jobs market showed early signs of slowing. The S&P/ASX 200 declined 69 points or 1.02 per cent to 6731. The retreat continued a burst of moves of...

Australian shares fell for the first time in three sessions as record results from energy giants Woodside and Santos were overshadowed by weak jobs data and renewed worries about rising rates. The S&P/ASX 200 dropped 78 points or 1.1...

It’s quarterlies season again as the ASX market announcements page becomes increasingly flooded with earnings lodgements.  The highlight today came from BNPL stock Zip, which reported strong growth. Is this the start of the BNPL turnaround...

In this week's Weekly Insights:-Investing In Non-Profitable Companies-Corporate Updates: Early Signals-Peak Resources?-FNArena TalksBy Rudi Filapek-Vandyck, Editor FNArenaInvesting In Non-Profitable CompaniesThe 2022 patience-testing, volat...

MELBOURNE, Australia, Oct. 20, 2022 /PRNewswire/ – Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today issues its Appendix 4C quarterly cash flow statement and accompanying Activities Report for the quarter ended 30 Septem...

A strong lead-in from Wall Street gave solid impetus to the Australian market on Tuesday, and the result was a lift of 114.8 points, or 1.7 per cent, in the benchmark S&P/ASX 200 (INDEXASX: XJO) Index, to 6779.2; while the broader S&amp...

ShareCafeEnergy only sector lagging: ASX closes 1.72% higher by Peter Milios   The ASX has continued rising since lunchtime. At the closing bell, the S&P/ASX 200 was 1.72 per cent or 114.80 points higher at 6779.20. The sector of the da...

ASX regains yesterday’s losses as volatility in the market continues All ASX sectors rose except Energy RBA deputy governor Michelle Bullock says RBA will keep lifting rates   The seesaw game continues as the ASX 200 gained 1.80% on Tuesd...

The S&P/ASX 200 Index (ASX: XJO) jumped higher on Tuesday, driven by tech shares. The index ended the day 1.72% higher at 6,779.2 points. Its strong performance followed Wall Street’s day in the green. The Dow Jones Industrial Averag...

The share market logged its highest close in a week and a half after a UK government backdown on a controversial tax plan helped trigger a massive relief rally on Wall Street. The S&P/ASX 200 jumped 115 points or 1.72 per cent to 677...

The S&P/ASX 200 Index (ASX: XJO) is back on form on Tuesday. In afternoon trade, the benchmark index is up 1.3% to 6,749.4 points. Four ASX shares that are climbing more than most today are listed below. Here’s why they are rising:...

The share market reversed yesterday’s loss after Wall Street welcomed a UK government decision to scrap unfunded tax cuts that sent tremors through financial markets.     The S&P/ASX 200 rallied 93 points or 1.39 per cent by mid-sess...

Telix (ASX:TLX) has announced that Health Canada has approved Illuccix gozetotide injection] for use in staging and re-staging intermediate and high-risk prostate cancer and localising tumour tissue in recurrent prostate cancer....